DRMA icon

Dermata Therapeutics

8 hedge funds and large institutions have $236K invested in Dermata Therapeutics in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
+4
Holders Change %
+100%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
1
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Acadian Asset Management
1
Acadian Asset Management
Massachusetts
$92K +$92K +375 New
VF
2
Virtu Financial
New York
$53K +$53K +214 New
Citadel Advisors
3
Citadel Advisors
Florida
$28.5K +$28.5K +115 New
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$20.9K +$20.9K +84 New
HWA
5
HCR Wealth Advisors
California
$19.8K +$19.8K +80 New
UBS Group
6
UBS Group
Switzerland
$11.6K +$5.91K +24 +104%
TRCT
7
Tower Research Capital (TRC)
New York
$9.38K -$247 -1 -3%
Wells Fargo
8
Wells Fargo
California
$1.16K -$1.16K -5 -50%
Renaissance Technologies
9
Renaissance Technologies
New York
-$34K -176 Closed